Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer
Yuezong Bai, Tong Xie, Zhenghang Wang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e004080-e004080
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 21
The role of microRNAs in the gastric cancer tumor microenvironment
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Recent Progress in Immunotherapy for Gastric Cancer
Jeesun Yoon, Tae‐Yong Kim, Do‐Youn Oh
Journal of the Korean Gastric Cancer Association (2023) Vol. 23, Iss. 1, pp. 207-207
Open Access | Times Cited: 29
Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects
Wanting Hou, Yaqin Zhao, Hong Zhu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15321-15321
Open Access | Times Cited: 23
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Landscape of four different stages of human gastric cancer revealed by single-cell sequencing
Xu-Shan Tang, Chunlei Xu, Na Li, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access | Times Cited: 1
N7-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation
Xiang Xu, Zhixin Huang, Hui Han, et al.
Cancer Letters (2025) Vol. 615, pp. 217566-217566
Open Access | Times Cited: 1
Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy
Fang-Lin Zhang, Da‐Qiang Li
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12815-12815
Open Access | Times Cited: 34
Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022
Yizhen Chen, Yifan Chen, Song Tan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 18
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
Bradley M. Haverkos, Önder Alpdoğan, Robert A. Baiocchi, et al.
Blood Advances (2023) Vol. 7, Iss. 20, pp. 6339-6350
Open Access | Times Cited: 18
The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape
Mikhail Salnikov, Katelyn M. MacNeil, Joe S. Mymryk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Current development of molecular classifications of gastric cancer based on omics (Review)
Yubo Ma, Zhengchen Jiang, Li-Bin Pan, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Open Access | Times Cited: 6
ACTA2Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
Sunho Park, John D. Karalis, Changjin Hong, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1077-1085
Open Access | Times Cited: 24
Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers
Zaki H. Hakami
Pathology - Research and Practice (2024) Vol. 255, pp. 155216-155216
Closed Access | Times Cited: 5
Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications—A Literature Review
Mengjiao Wu, Chenjun Tian, Zhenwei Zou, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3547-3547
Open Access | Times Cited: 5
The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
Anna Koerner, Ryan H. Moy, Sandra Ryeom, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4114-4114
Open Access | Times Cited: 11
Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies
Haoxin Peng, Xiangrong Wu, Cheng Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 3
Open Access | Times Cited: 4
Current Landscape of Molecular Biomarkers in Gastroesophageal Tumors and Potential Strategies for Co-Expression Patterns
M. Korpan, Hannah Christina Puhr, J.M. Berger, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 340-340
Open Access
Comprehensive Analysis of Clinical and Molecular Features in Cancer Patients Associated With Major Human Oncoviruses
Ahmed Mohamed, Rongzhuo Long, Yin He, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
An Overview of Predictive Biomarkers and Detection Approaches for Immunotherapy Response in GI Malignancies
Xinyu Chai, Yiwen Zhang, Zhihui Shi, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
The artificial intelligence revolution in gastric cancer management: clinical applications
Runze Li, Jingfan Li, Yuman Wang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity
Da-yan Zhang, Zhihua Zhang, Wenting Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Contemporary management of advanced gastric and gastroesophageal adenocarcinomas
Jane E. Rogers, Jaffer A. Ajani
Expert Review of Anticancer Therapy (2025), pp. 1-7
Closed Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Immune checkpoint inhibitors in patients with advanced gastric cancer: a multi-institutional retrospective real-world study
A. B. Rays, М. Yu. Fedyanin, D. V. Popov, et al.
(2025)
Open Access
Page 1 - Next Page

Scroll to top